Professor Paul Myles – Presentations

April 1996; 11th World Congress of Anaesthesiologists (Sydney): Anaesthesia for bilateral sequential lung transplantation.

July 1999; 11th ASEAN Congress of Anaesthesiologists (Kuala Lumpur, Malaysia): (i) Impact of epidural analgesia/anaesthesia on patient outcome –the MASTER Trial; (ii) Truth and lies of statistics; (iii) Understanding methodology and statistics.

March 2000; 74th International Anesthesia Research Society Clinical Scientific Congress (Honolulu, Hawaii): (i) Fast tracking cardiac surgery; (ii) Safe single lung anesthesia.

June 2000; 12th World Congress of Anaesthesiologists (Montreal, Canada): Anaesthesia for end-stage lung disease: lessons from lung transplantation.

June 2000; 7th International Congress of Cardiothoracic & Vascular Anesthesia (Quebec, Canada): Anesthesia for lung reduction surgery.

May 2001; Australian and New Zealand College of Anaesthetists  & Hong Kong College of Anaesthetists ASM (Hong Kong): (i) Why do large trials?; (ii) Epidurals and abdominal surgery.

May-June 2001; SMART 2001 (Simposio e Mostra di Anestesia Rianimazione e Terapia Intensiva), Milan, Italy: Quality in anaesthesia.

October 2001; American Society of Anesthesiologists Annual Meeting (New Orleans): Evidence-based anesthesia: meta-analysis or large randomized trials?

March 2002: New Zealand Cardiac Surgery Meeting (Tongariro): (i) Anaesthetic issues with aortic surgery; (ii) Neurocognitive function and quality of life after cardiac surgery.

April 2002; 24th Annual Meeting of the Society of Cardiovascular Anesthesiologists (New York): Combined cardiac and pulmonary surgery: its role and applications.

August  2003; Edinburgh Anaesthetic Festival (Edinburgh, Scotland): (i) Awareness and BIS monitoring,  (ii) EBM and large multicentre trials in anaesthesia, (iii) The MASTER Trial, (iv) Anaesthesia for end-stage lung disease.

September 2003; 1st International Congress of Evidence-based Perioperative Medicine (Geneva, Switzerland): (i) Why we need large trials in anaesthesia.

September 2003; Grand Round, St.John’s Hospital,  Edinburgh:  smoking and anaesthesia.

October 2003; American Society of Anesthesiologists meeting (San Francisco, USA): (i) Panel: Current concepts in thoracic anesthesia; (ii) Workshops: Clinical considerations in thoracic anesthesia.

October 2003; Columbia University (New York, USA) Visiting Professor and Grand Rounds: EBM and large trials in anesthesia.

May 2004; 6th International Symposium on Memory and Awareness in Anaesthesia and Intensive Care (University of Hull, UK): The B-Aware Trial.

October 2005; American Society of Anesthesiologists Annual Meeting (New Orleans): Monitoring for awareness.

October 2005; Duke University (North Carolina, USA) Visiting Professor and Grand Rounds: Large multicenter trials in anesthesia.

November 2005; Cleveland Clinic (Ohio, USA) Visiting Professor and Grand Rounds: Reducing the risk of awareness in anesthesia.

March 2006; Joint Royal College of Anaesthetists and British Journal of Anaesthesia Symposium on Clinical Monitoring (London): Evaluating depth of anaesthesia monitoring.

August 2006; NZ Society of Anaesthetists ASM (Dunedin): (i) Does quality of anaesthesia significantly affect outcomes after surgery?, (ii) Does Anaesthesia always present awareness, (iii) Evidence-based Practice.

October 2006; Society for Neurosurgical Anesthesia and Critical Care (SNACC) 34th annual meeting (Chicago): Brain Function Monitoring and Awareness

October 2006; American Society of Anesthesiologists Annual Meeting (Chicago): Processed EEG to prevent awareness during anesthesia.

October 2006; XIV Chilean Congress of the Anesthesiology (Viña del Mar, Chile): (i) Epidural anesthesia and analgesia in major surgery: Do they improve the outcome?; (ii) Anesthetic techniques in high-risk patients: Do they modify the outcome?; (iii) Anesthetic controlled interventions and postoperative outcome: What has been demonstrated?”

November 2006; 12th Asian Australasian Congress of Anaesthesiologists (Singapore): (i) Management of hypoxaemia during one-lung ventilation, (ii) Anaesthesia for end-stage lung disease. (iii) Epidural analgesia for video-assisted lung resection (debate).

November 2006; Combined Hong Kong College of Anaesthesiologists and The Society of Anaesthetists of Hong Kong, annual scientific meeting (Hong Kong): (i) One-lung ventilation: what works and what’s new, (ii) Post-thoracotomy complications, (iii) Smoking and anesthesia.

June 2007; Canadian Anesthesiologists’ Society’s 2007 Annual Meeting (Calgary): (i) Risks and benefits of nitrous oxide: is this the end of an era? (ii) Paravertebral block in thoracotomy.

October 2007; 7th Meeting of the Asian Society of Cardiothoracic Anesthesia (New Delhi): Evidence-based anaesthesia and large trials.

November 2007; 2nd International Symposium on Anaesthesia for Minimally Invasive Surgery (Riyadh): (i) Preoperative assessment of the thoracic surgery patient, (ii) Aspirin and cardiac surgery, (ii) Meta-analysis.

March 2008; 14th World Congress of Anesthesiologists (Cape Town): (i) Anterior mediastinal masses, (ii) Anesthesia for lung transplantation, (iii) Nitrous oxide: is it obsolete?

June 2008; Society of Cardiovascular Anesthesiologists 30th Annual Meeting (Vancouver): Nuances of large trials.

September 2008; Association of Anaesthetists of Great Britain and Ireland Annual Congress (Torquay, UK).  The Intavent Lecture: Nitrous Oxide – has it overstayed its welcome?

October 2008; Grand rounds, Beth Israel Deaconess Medical Center and Boston Children’s Hospital, Harvard University (Boston): Large multicenter trials in anesthesia.

October 2008; American Society of Anesthesiologists Annual Meeting (Orlando): Update on BIS monitoring.

April 2009; 2nd World Congress of Intravenous Anaesthesia (SIVA) meeting (Berlin): Nitrous oxide

June 2009; Irish College of Anaesthetists annual meeting (Dublin): (i) Nitrous oxide, (ii) Translating evidence into practice.

June 2009; Visiting professor, University Medical Center Utrecht: (i) Mega-trials in anaesthesia,  (ii) BIS monitoring and awareness (iii)

June 2009; The European Anaesthesiology Congress: Euroanaesthesia 2009 (Milan): BIS monitoring and awareness.

June 2010; The European Association of Cardiothoracic Anaesthesiologists meeting (Edinburgh): (i) Plenary lecture – The operation was a success but the patient died; what is a meaningful outcome for patients undergoing heart surgery? (ii) Anaesthesia for resection of anterior mediastinal masses.

July 2010; Elsevier Advanced Medical Presentation Skills Training Seminar: Designing Good Anesthesiology Clinical Research that Gets Published (China): (i) Designing a good anesthesiology study and an outline of publishable papers, (ii) New insights on clinical pain research.

Aug 2010; Dannemillar Anesthesia Update CME meeting (Maui): (i) What have clinical trials (B-AWARE, B-UNAWARE) taught us about awareness monitoring? (ii) The SAFE (Saline Albumin Fluid Evaluation) trial and what it means to the eternal crystalloid-colloid debate. (iii) Antifibrinolytics and cardiac surgery:  Did the baby go out with the bathwater? (iv) The ENIGMA trial and its implications for our ongoing use of nitrous oxide.

Nov 2010; 57th Brazilian Anesthesia Congress (Porto Alegre, Brazil): (i) Neurotoxicity of inhaled anesthetics in pediatric populations: an overview of the subject in 23010, (ii) The bispectral index as a monitoring device of brain status during aesthesia: what is real and what are the possibilities?, (iii) Morbidity of nitrous oxide: facts and myths.

Jan 2011; Saudi Anesthetic Association (Jeddah): (i) Alpha2-agonists, (ii) Translating evidence into practice, (iii) Large multicentre trials in anaesthesia, (iv) Update on nitrous oxide.

July 2011; Plymouth Medical School (UK): Search for the truth.

Oct 2011; University of Wisconsin (USA) Ralph Waters Visiting Professor: (i)  Epidurals for major surgery: the MASTER trial, (ii)  The ENIGMA trial and its implications for our ongoing use of nitrous oxide.

Oct 2011; American Society of Anesthesiologists Annual Meeting (Chicago): Meaningful anesthesia related outcomes.

Oct 2011; ICSL/UCL Dingle Conference (i) Global Perspective-who should pay for outcome studies? (ii) BIS monitoring and awareness, (iii) Spurious thinking in research, (iv) Update on nitrous oxide.

March 2012; International Cardiothoracic Symposium 2012 (Iguazu Falls, Argentina): Depth of Anaesthesia monitoring: Daydream believer?

March 2012; 15th World Congress of Anaesthesiologists (Buenos Aries, Argentina): (i) nitrous oxide – is it obsolete? (ii) fast-track surgery – design issues.

Sept 2012; 46th Mexican Congress of Anesthesiology (Cancun, Mexico): (i) outcomes in fast-track programs. (ii) Real and potential short, medium, and long term outcomes associated with thoracic epidural anesthesia.

November 2012; 13th International Congress of Cardiothoracic and Vascular Anesthesia (Auckland, NZ): (i) bias and the RCT, (ii) The POISE-II trial.

November 2012; PHRI Lectureship (Population Health Research Institute, McMaster University, Canada): (i) Large multicentre trials in anaesthesia; (ii) Aspirin, antifibrinolytics and cardiac surgery: evidence and controversy; (iii) smoking and anaesthesia.

March 2013; Rank Lectureship (Royal College of Anaesthetists [UK] Anniversary meeting 2013):

Perioperative medicine-The future role of the anaesthetist? (i) Large randomised controlled trials  (ii) Fluid restriction for abdominal surgery.

July 2013; University College London: Evidence-based Perioperative Medicine. Ernest Henry Starling Plenary Lecture:  (i) How clinical trials are changing the face of perioperative medicine; (ii) Measuring quality of recovery after surgery and anaesthesia.

November 2013; Dutch Anaesthesia Research Society. (i) Innovation in anaesthesia research; (ii) The future of large trials.

October 2013; American Society of Anesthesiologists annual scientific meeting (San Francisco, US): FAER Clinical Research session: Large trials in anesthesia

November 2013; Association of Cardiothoracic Anaesthetists annual meeting (Nottingham, UK): (i) Perioperative TOE – Is it value for money?; (ii) Answering the big questions in cardiothoracics; (iii) Nitrous oxide – the end of the road?

February 2014: 14th Asian Australasian Congress of Anaesthesiologists (Auckland, NZ). Plenary speaker: (i) BIS for prevention of awareness: where are we now? (ii) Medical Research, Bias and Error – who or what is the third man?

April 2014: Weill-Cornell Medical College (New York, USA). Visiting Professor and Grand Rounds: Restrictive or Liberal Fluids for Abdominal Surgery.

April 2014; Wake Forest University Medical Centre (North Carolina, USA). Visiting Professor and Grand Rounds: Restrictive or Liberal Fluids for Abdominal Surgery.

October 2014; 23rd International Society for Anaesthetic Pharmacology (ISAP) (New Orleans, USA): Nitrous oxide

October 2014; American Society of Anesthesiologists annual scientific meeting (New Orleans, USA): The ENIGMA-II trial

November 2014; College of Anaesthetists of Ireland winter college lecture (Dublin): The safety of nitrous oxide: the findings of the ENIGMA-II trial; and the Irish Standing Committee/AAGBI  Meeting: BIS for prevention of awareness: where are we now?

March 2015; South African Society of Anaesthesiology national congress (Durban, Cape Town, Johannesburg): (i) How to survive intraoperative pulmonary embolism, (ii) ENIGMA-II and can we teach an old dog new tricks?, (iii) Does my choice of anaesthetic agent influence perioperative outcomes?


May 2015; World Congress of Enhanced Recovery after Surgery and Perioperative Medicine (Washington): (i) Goal directed vs. liberal vs. Restrictive – is it all in a name? (ii) Debate 2 – GDFT is evidence based and should be used in all major surgery, (iii) What are the end-points in major trials? (iv) Big Trials – what we know and what is in the pipeline.

May 2015; Harvard Medical School Anesthesiology Update 2015 (Boston): (i) What is a poor outcome after surgery and anesthesia? (ii) Understanding evidence and the role of large trials.

June 2015; 15th EBPOM: Congress in Evidence Based Perioperative Medicine (London)

October 2015: American Society of Anesthesiologists annual scientific meeting (San Diego, USA): Co-Chair Breaking Trials session, (ii) A Few New Papers From Outside Anesthesia Which Can Affect Your Practice.

October 2015: University of Pennsylvania School of Medicine, Dept of Anesthesiology and Critical Care (Philadelphia, USA): The 19th Annual James E. Eckenoff Lecture: What is a poor outcome after anesthesia and surgery: quality of recovery and disability-free survival.

April 2016; Washington University (St.Louis, USA): The 28th Annual CR Stephen Lecture: The special value and importance of large trials in perioperative medicine.

June 2016; Perioperative Mortality Review Committee; Health Quality and Safety Commission, New Zealand (Wellington, NZ): An overview of perioperative mortality reviews.

September 2016; 16th World Congress of Anaesthesiologists (Hong Kong): Chair, Perioperative Medicine programme. (i) Measuring quality after anaesthesia and surgery (ii) Standardized endpoints in perioperative clinical trials.

September 2016; Association of Anaesthetists of Great Britain and Ireland Annual Congress (Birmingham, UK).  (i) The John Snow Lecture: Quality of recovery and disability-free survival, (ii) Nitrous oxide: friend or foe?

September 2016; Karolinska University Hospital, and the National Swedish Anaesthesia (SFAI) scientific meeting . The Torsten Gordh lecture: (i) Disability-free survival and patient-centred perioperative outcomes, (ii) RELIEF trial, fluids and goal-directed therapy.

October 2016; American Society of Anesthesiologists annual scientific meeting (Chicago, USA): Results of the ATACAS trial: tranexamic acid in cardiac surgery

June 2017; The European Anaesthesiology Congress: Euroanaesthesia 2017 (Geneva): Large trials in anaesthesia.

September 2017; 19th Congress of the Polish Society of Anesthesiology and Intensive Therapy (Bydgoszcz, Poland)

October 2017; 19th Current Controversies in Anaesthesia and Perioperative Medicine (Dingle, Ireland).